Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak

What happened

Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.

Summary assembled by rule from the sources below

Timeline

1. 18:10
   First appeared on MarketWatchMMarketWatch
2. 18:10
   Forbes Business started reportingFForbes Business

Sources